Table 1

Demographic and Clinical Characteristics of the Patients

Placebo (n = 11)Enalaprilat (n = 11)
Age (yrs)50 ± 354 ± 3
Gender, M/F7/49/2
Hypertension98
Smoking58
Diabetes mellitus43
Previous CABG00
Previous PTCA01
Left ventricular ejection fraction (%)58 ± 154 ± 2
CCS anginal syndrome on admission
 1–276
 3–445
Interval between most recent angina and PTCA (days)3.8 ± 1.14.0 ± 1.2
Antianginal medications
 Long-acting nitrates1110
 Calcium channel blocking agents10
 Beta-blocking agents1011

CABG = coronary artery bypass graft; CCS = Canadian Cardiovascular Society; PTCA = percutaneous transluminal coronary angioplasty.